Dotacje
Wszystkie dotacje
1,472 wyników · strona 13 z 74
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)17 Nov 2026pozostało 45 dni
- National Science Foundation Translation to Practice17 Nov 2026pozostało 45 dniUS$30,000,000
- Native Entities Grant Program17 Nov 2026pozostało 45 dni
- Tribal Broadband Connectivity Program17 Nov 2026pozostało 45 dni
- Small Business Innovation Research and Small Business Technology Transfer Programs Phase II17 Nov 2026pozostało 45 dniUS$24,750,000
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)18 Nov 2026pozostało 46 dni
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)18 Nov 2026pozostało 46 dni
- National Science Foundation Fostering Interdisciplinary Networks to Develop Emergent and Responsive Solutions Foundry (NSF FINDERS FOUNDRY)18 Nov 2026pozostało 46 dniUS$8,500,000
- DoW Orthopaedic, Applied Research Award18 Nov 2026pozostało 46 dniUS$3,800,000
- DoW Orthopaedic, Clinical Research Award18 Nov 2026pozostało 46 dniUS$13,600,000
- DoW Rare Cancers Idea Development Award18 Nov 2026pozostało 46 dniUS$7,350,000
- DoW Rare Cancers Resource and Community Development Award18 Nov 2026pozostało 46 dniUS$5,600,000
- DOW Combat Readiness – Medical Research Program Translational Research Award18 Nov 2026pozostało 46 dniUS$4,370,000
- DoW Breast Cancer, Breakthrough Award Levels 1 and 218 Nov 2026pozostało 46 dniUS$10,600,000
- DoW Breast Cancer, Clinical Research Extension Award18 Nov 2026pozostało 46 dniUS$8,400,000
- DARRP Restoration Implementation Grants (2026)18 Nov 2026pozostało 46 dni
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)19 Nov 2026pozostało 47 dni
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)19 Nov 2026pozostało 47 dni
- DoW Toxic Exposures Clinical Trial Award19 Nov 2026pozostało 47 dniUS$4,500,000
- DoW Toxic Exposures Investigator Initiated Research Award19 Nov 2026pozostało 47 dniUS$2,400,000